Skip to main content
Erschienen in: BMC Public Health 1/2019

Open Access 01.12.2019 | Research article

Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study

verfasst von: Nancy P. Gordon, Teresa Y. Lin, Jyoti Rau, Joan C. Lo

Erschienen in: BMC Public Health | Ausgabe 1/2019

Abstract

Background

Few large cohort studies have examined the prevalence of diabetes mellitus (DM), hypertension (HTN), coronary artery disease (CAD), obesity, and smoking among middle-aged and older adults in the major Asian-American ethnic groups and Native Hawaiian/Pacific Islanders (PIs). The aim of this study was to evaluate how prevalence of these conditions and risk factors differs across Asian-American and PI ethnic groups and compares with an aggregated All Asian-American racial group.

Methods

This study used a cohort of 1.4 million adults aged 45 to 84 who were Kaiser Permanente Northern California health plan members during 2016. The cohort included approximately 274,910 Asian-Americans (Chinese, Filipino, Japanese, Korean, Southeast Asian, South Asian, other), 8450 PIs, 795,080 non-Hispanic whites, 107,200 blacks, and 210,050 Latinos. We used electronic health record data to produce age-standardized prevalence estimates of DM, HTN, CAD, obesity (using standard and Asian thresholds), and smoking for men and women in all racial/ethnic subgroups and compared these subgroups to an aggregated All Asian-American racial group and to whites, blacks, and Latinos.

Results

We found large differences in health burden across Asian-American ethnic subgroups. For both sexes, there were 16 and > 22 percentage point differences between the lowest and highest prevalence of DM and HTN, respectively. Obesity prevalence among Asian subgroups (based on an Asian BMI ≥ 27.5 kg/m2 threshold) ranged from 14 to 39% among women and 21 to 45% among men. Prevalence of smoking ranged from 1 to 4% among women and 5 to 14% among men. Across all conditions and risk factors, prevalence estimates for Asian-American and PI ethnic groups significantly differed from those for the All Asian-American group. In general, Filipinos and PIs had greater health burden than All Asians, with prevalence estimates approaching those of blacks.

Conclusions

In a population of middle-aged and older adult Northern California health plan members, we found substantive differences in prevalence of chronic cardiovascular conditions, obesity, and smoking across Asian-American ethnic groups and between Asian-American ethnic groups and an aggregated All Asian racial group. Our study confirms that reporting statistics for an aggregated Asian-American racial group masks meaningful differences in Asian-American ethnic group health.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12889-019-7683-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BMI
Body mass index
CAD
Coronary artery disease
CMS
Centers for Medicare and Medicaid Services
DECKA2016
Demographically Enriched Cohort of Kaiser Adults 2016
DM
Diabetes mellitus
EHR
Electronic health record
HTN
Hypertension
ICD
International Classification of Diseases
IOM
Institutes of Medicine
KPNC
Kaiser Permanente Northern California
MU
Meaningful Use
PAMF
Palo Alto Medical Foundation
PI
Native Hawaiian/Pacific Islander
U.S.
United States of America

Background

Asian-Americans are among the fastest growing of all major racial or ethnic groups in the United States [1]. Asians comprised 5% of the U.S. population in 2010, but are expected to be over 10% by 2050, a projected growth from 14 million to 38 million [2, 3]. However, there is scant information about Asian-American health and healthcare utilization. State and national health surveys have generally not reported statistics for Asian-Americans, in part due to survey subgroup samples that are insufficiently-sized for producing stable prevalence estimates. Furthermore, despite the cultural and sociodemographic heterogeneity of the Asian-American population, when Asian health data are reported, the statistics are seldom disaggregated by ethnic group and often include Native Hawaiian/Pacific Islanders (PI). Consequently, there is currently little available information to examine differences in health and healthcare use among Asian and PI ethnic groups and how health characteristics of individual Asian ethnic groups differ from characteristics of the broader Asian/PI group [4].
In 2011, as part of the U.S. Centers for Medicare and Medicaid Services (CMS) Stage 2 Meaningful Use (MU) requirements, health care organizations receiving CMS funds were incentivized to ascertain race/ethnicity and language preference directly from patients to populate their electronic health record (EHR) [5]. CMS intended for health care organizations to use this race/ethnicity information in conjunction with other EHR data to identify and reduce health and health care disparities [6]. To meet MU requirements, CMS deemed use of a single Asian race category as acceptable for recording and analyzing EHR racial/ethnicity data of people with different Asian ethnic backgrounds [6]. However, there is concern among researchers and advocacy groups in the medical and public health communities that the broad Asian or Asian/PI race category is too heterogeneous to be meaningful for research and reporting purposes because it may mask important differences across Asian ethnic groups [4, 710]. A 2009 report by the Institutes of Medicine (IOM) Subcommittee on Standardized Collection of Racial/Ethnicity Data for Healthcare Quality Improvement recommended that more granular race and ethnicity information be captured in EHRs [11].
Research comparing health status and health-related risks across multiple Asian-American ethnic groups is limited, but there is a growing body of evidence that health disparities exist by ethnicity within the broader Asian group. Studies conducted using national and state survey data have found significant differences across Asian ethnic groups in prevalence of obesity [1215], smoking [12, 14, 16], diabetes [12, 1719], high blood pressure [12, 15, 19], heart disease [12], and multiple chronic conditions [20]. However, despite use of pooled data from several survey cycles, the Asian ethnic subgroup samples used for these survey-based studies have been relatively small, leading to inconsistent findings across studies. Small subgroup samples have also limited the ability to examine variation across Asian ethnic groups separately for women and men and to focus analyses on the middle-aged and older adult segment of the population which has a significantly higher prevalence of chronic health conditions than the population aged 18 and over.
Mortality data and EHR-based studies have also shown differences among North American Asian ethnic groups. A Canadian death record study found that the mortality rate due to cardiovascular disease was significantly higher for South Asian than Chinese adults [21] and a U.S. study found higher CHD mortality rates among South Asians and Filipinos compared to Chinese, Japanese, Korean, and Vietnamese Americans [22]. The Canadian SHARE study based on clinical data for community-recruited samples of South Asian and Chinese adults aged 35–75 found that South Asians were more likely than Chinese adults to have a history of coronary heart disease, diabetes, and cardiovascular disease [23]. Studies conducted with medical record data for cohorts of Asian adult members of two Northern California health plans, Kaiser Permanente Northern California (KPNC) and Palo Alto Medical Foundation (PAMF), found significant variation across Asian ethnic groups in obesity [24], Type 2 diabetes [25, 26], hypertension [24], dyslipidemia [27], coronary heart disease [28, 29], stroke [29], peripheral vascular disease [29], and osteoporotic bone fractures [30].
In this study, we compared age-standardized prevalence of three cardiovascular conditions (diagnosed diabetes, hypertension, coronary artery disease), obesity, and smoking status among male and female KPNC health plan members aged 45–84 in six Asian-American (Chinese, Korean, Japanese, Southeast Asian, Filipino, and South Asian) and PI ethnic groups. We then compared these ethnic group prevalence estimates with prevalence for an aggregated Asian-American racial group and prevalence for whites, blacks, and Hispanic/Latinos. We focused on a middle and older adult age group because research on other populations suggests that the prevalence of these chronic conditions is very low among younger adults.

Methods

Setting

Kaiser Permanente Northern California (KPNC) provides integrated primary and specialty health care to a racial/ethnically and sociodemographically diverse membership that includes over 3.2 million adults who mostly reside in the San Francisco Bay and Greater Bay Area, Sacramento area, Silicon Valley, and Central Valley. The KPNC adult membership is very similar to the insured population of Northern California with regard to sociodemographic and health characteristics [31].

Study population

To estimate and compare prevalence of health conditions, health risks, and health care utilization across Asian-American ethnic groups in KPNC and examine how reporting data for an aggregated Asian-American racial group may mask significant ethnic group variation, we created a race/ethnicity and language cohort, DECKA2016 (for Demographically Enriched Cohort of Kaiser Adults, calendar year 2016). This cohort is comprised of over 2.4 million adults aged 20–89 who were KPNC members for all 12 months of calendar year 2016 and for whom we could assign race/ethnicity based on information in their EHR, information from surveys and other data sources that was not entered into their EHR, and surname coding. Approximately half a million of the cohort members are Asians for whom we were able to assign to a specific Asian ethnic subgroup. A description of the methodology used to create our large population cohort and of the final cohort race/ethnicity subgroups is found in Additional file 1. We are able to link this cohort with EHR diagnosis, procedure, healthcare utilization, and Census-derived data to study variation in prevalence of chronic health conditions, obesity, smoking, and use of health care services across adult Asian-American ethnic groups. While this cohort was primarily created to study Asian ethnic groups, we also included data for white, black, and Hispanic/Latino adults for comparison purposes.

Description of study cohort

For this study, we used DECKA2016 cohort data for 1.4 million members who were aged 45–84 on December 31, 2016 and had an EHR-coded sex of male or female. We restricted our Asian ethnic groups to adults we classified as Chinese (n = 87,128), Filipino (n = 88,691), Korean (n = 8910), Japanese (n = 16,886), Southeast Asian (n = 30,910), or South Asian (n = 35,565), but the aggregated All Asian group (n = 274,909) also includes Central/other Asian (n = 100, excluding Iranian/Persian), Chinese or Korean surname (n = 249), and known Asians whose ethnicity could not be specified based on available information or surname coding (Asian NSP, n = 6470). PIs (n = 8453), whites (n = 795,079), blacks (107,205), and Hispanic/Latinos (n = 210,050) were also included for comparison purposes. In this cohort, Chinese refers to people with ethnic origins in China, Taiwan, and Hong Kong, including ethnic Chinese living in other Asian countries. Southeast Asians were people not of Chinese ethnicity who had ethnic origins in Vietnam, Laos, Cambodia, Thailand, Indonesia, Singapore, Myanmar, or Malaysia. South Asians were those with ethnic origins in India, Pakistan, Afghanistan, Bangladesh, Sri Lanka, Nepal, or Bhutan, or who were Fijian Indian. Central/Other Asian does not include Iranian/Persian or Turkish, who are grouped with Middle Eastern. Native Hawaiian/Pacific Islanders included people whose race or ethnicity codes or primary language indicated Native Hawaiian, Fijian, Guamanian, Chamorro, Samoan, Polynesian, Tahitian, Tongan, or Micronesian. Hispanic/Latino adults were those identified as Hispanic/Latino race or ethnicity and met Office of Management and Budget (OMB) criteria for Latino (i.e., excludes people with ethnicity codes in the EHR for Spain, Italy, Portugal, Brazil, and other countries where Spanish was not the predominant language) [6].
Approximately 94% of PIs, 83% of Filipinos, 82% of Japanese, 81% of Chinese, 66% of Koreans, 60% of Southeast Asians, and 51% of South Asians were assigned to an ethnicity based on self-reported ethnicity information in their EHR or data from through clinical, research and operational patient questionnaires that did not feed into the EHR; the rest were assigned based on surname [32]. Of adults in the aggregated All Asian group, 17.7% had a preferred language other than English in the EHR (by ethnic group, 30.9% of Chinese, 31.7% of Korean, 32.1% of Southeast Asian, 10.8% of South Asian, 4.9% of Filipino, and 4.7% of Japanese), as did 2.0% of PIs. Approximately 3.4% of Asians were missing language preference data (range 1.6% of Filipinos to 5.1% of Chinese and 10% of Asian NSP). Table 1 shows the age distribution of the 11 racial/ethnic subgroups reported on in the subsequent tables.
Table 1
Age composition of study cohort ages 45–84 prior to standardization
Sex
Race/Ethnicity
45–54 yr
55–64 yr
65–74 yr
75–84 yr
  
N
%
N
%
N
%
N
%
All
All Asian
104,770
38.1
88,192
32.1
56,557
20.6
25,390
9.2
 
Chinese
29,827
34.2
28,106
32.3
19,851
22.8
9344
10.7
 
Korean
3235
36.3
2620
29.4
1993
22.4
1062
11.9
 
Japanese
4428
26.2
5427
32.1
4342
25.7
2689
15.9
 
Southeast Asian
15,307
49.5
9574
31.0
4545
14.7
1484
4.8
 
Filipino
31,613
35.6
29,512
33.3
19,222
21.7
8344
9.4
 
South Asian
17,029
47.9
10,701
30.1
5642
15.9
2193
6.2
 
Native Hawaiian/Pacific Islander
3814
45.1
2882
34.1
1325
15.7
432
5.1
 
White non-Hispanic
216,917
27.3
259,584
32.7
215,219
27.1
103,359
13.0
 
African-American/Black
36,565
34.1
36,295
33.9
23,270
21.7
11,075
10.3
 
Hispanic/Latino
91,848
43.7
65,763
31.3
34,753
16.6
17,686
8.4
Women
All Asian
56,397
37.9
47,591
32.0
30,917
20.8
14,000
9.4
 
Chinese
16,559
35.2
15,129
32.2
10,616
22.6
4730
10.1
 
Korean
1789
34.8
1553
30.2
1213
23.6
583
11.4
 
Japanese
2650
26.8
2991
30.2
2476
25.0
1774
17.9
 
Southeast Asian
7324
48.5
4734
31.3
2300
15.2
746
4.9
 
Filipino
18,072
35.5
16,815
33.0
11,071
21.7
4999
9.8
 
South Asian
7940
48.3
4898
29.8
2609
15.9
983
6.0
 
Native Hawaiian/Pacific Islander
1839
45.4
1354
33.4
633
15.6
225
5.6
 
White non-Hispanic
111,693
26.5
136,177
32.3
116,410
27.6
57,497
13.6
 
African-American/Black
20,316
33.4
20,425
33.6
13,511
22.2
6544
10.8
 
Hispanic/Latino
45,418
41.9
33,921
31.3
18,936
17.5
10,091
9.3
Men
All Asian
48,373
38.4
40,601
32.2
25,640
20.4
11,390
9.0
 
Chinese
13,268
33.1
12,977
32.4
9235
23.0
4614
11.5
 
Korean
1446
38.3
1067
28.3
780
20.7
479
12.7
 
Japanese
1778
25.4
2436
34.8
1866
26.7
915
13.1
 
Southeast Asian
7983
50.5
4840
30.6
2245
14.2
738
4.7
 
Filipino
13,541
35.9
12,697
33.7
8151
21.6
3345
8.9
 
South Asian
9089
47.5
5803
30.3
3033
15.9
1210
6.3
 
Native Hawaiian/Pacific Islander
1975
44.9
1528
34.7
692
15.7
207
4.7
 
White non-Hispanic
105,224
28.2
123,407
33.1
98,809
26.5
45,862
12.3
 
African-American/Black
16,249
35.0
15,870
34.2
9759
21.0
4531
9.8
 
Hispanic/Latino
46,430
45.7
31,842
31.3
15,817
15.6
7595
7.5
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table (eg, Central Asians and those who could not be assigned to a more granular Asian ethnicity). This group does not include Native Hawaiian/Pacific Islanders

Study variables

This study examined differences in prevalence of diabetes mellitus, hypertension, obesity, and current smoking for ages 45–84 and coronary artery disease (CAD), for ages 45–84 and 65–84 using EHR-derived data. The lists of ICD-9 and ICD-10 diagnosis codes for diabetes, hypertension, and CAD used to abstract EHR data for the cohort are found in Table 2. To be assigned as having a condition, adults must have had ≥1 office visit diagnosis code for that condition during calendar years 2015 and 2016 or a diagnosis code for that condition on the problem list in December 2016. Diabetes was assigned based on inclusion in the KPNC Diabetes Registry in December 2016, as identified through inpatient and outpatient diagnoses, lab test results, and pharmacy use (see Karter et al. for specifications [25]). BMI was calculated based on weight in EHR for the closest office visit to December 1, 2016 (date range: January 1, 2016 – December 31, 2016) and valid height on date closest to the date of that weight. For people with a suspected invalid height (< 40 in. or > 84 in.), weight (< 70 lbs. or > 500 lbs.) or BMI (< 14 or > 50), we examined additional heights and weights taken during that interval and either replaced the inaccurate values with a qualifying value or set BMI to missing. A valid BMI was available for approximately 74% of the All Asian group in our cohort aged 45–84 (range 72 to 76%). We classified Asians and other adults as obese based on the standard BMI threshold (≥ 30 kg/m2) and additionally classified Asians and PIs as obese using the lower Asian obesity threshold (≥ 27.5 kg/m2) recommended by the World Health Organization [33]. Smoking status (current smoker or non-smoker) was based on EHR tobacco use data on visit date closest to December 1, 2016. Adults who did not have smoking status data captured during calendar years 2015 or 2016 but who had information in their EHR for the three years prior (2012–2014) or three months after (January–March 2017) that indicated they had never smoked were coded as non-current smokers. Current smoking status was obtained for nearly 99% of all racial/ethnic groups.
Table 2
ICD codes used to assign cohort to chronic condition status
Condition
ICD-10 codes
ICD-9 codes
Diabetes Mellitus
Presence in KPNC Diabetes Registry (based on inpatient or outpatient ICD codes, lab test results and medication use. See Karter et al. article for specifics [25]
Hypertension
I13.0, I13.1, I13.2, I13.9, I15.0, I15.8, I15.9, I10, I11.0, I11.9, I12.0, I12.9, H35.039
362.11, 401.0, 401.1, 401.9, 402.00, 402.01, 402.10, 402.11, 402.90, 402.91, 403.00, 403.01, 403.10, 403.11, 403.90, 403.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 405.01, 405.09, 405.11, 405.19, 405.91, 405.99
Coronary artery disease
I20.0, I20.1, I20.8, I20.9, I21.02, I21.09, I21.11, I21.19, I21.21, I21.29, I21.3, I21.4, I24.0, I24.1, I25.19, I25.82, I25.810, I25.811, I25.812, I25.5, I25.89, I25.9
410.00, 410.01, 410.02, 410.10, 410.11,410.12, 410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 410.90, 410.91, 410.92, 411.0, 411.1, 411.81, 413.0, 413.1, 413.9, 414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.2, 414.8, 414.9

Data analysis

Study data were analyzed using SAS version 9.4 (SAS Institute, Cary, NC). To enable direct comparison of racial and ethnic groups unaffected by differences in the age-sex composition of the subgroups, we used a SAS Proc Surveyreg procedure recommended by the Centers for Disease Control and Prevention for direct standardization of prevalence estimates [34] using 2016 US Census data for men and women aged 45–84. Prevalence estimates for men and women were age-standardized using weighting factors from four age groups (45–54 years, 0.3367; 55–64 years, 0.3261; 65–74 years, 0.2252; 75–84 years, 0.1120). Prevalence estimates for men and women combined were age-sex standardized using eight age-sex subgroups (Male, Female x ages 45–54, 55–64, 65–74, 75–84). There were approximately equal percentages of men and women in each age group. Prevalence estimates restricted to ages 65–84 (CAD prevalence) were standardized using the distributions for two age groups (65–74 and 75–84). We compared non-standardized prevalence with the age- and age-sex standardized prevalence and found that they were nearly identical for almost every estimate, although standardized prevalence estimates for Japanese deviated from the non-standardized estimates by up to + 2 percentage points.
We created 99% confidence intervals around our prevalence estimates and used non-overlap of the confidence intervals of two racial/ethnic subgroups as a conservative indicator of a statistically significant difference at the P < .01 level. We defined meaningful differences between racial/ethnic subgroups (for men and women combined and by sex) and in comparison to the All Asian group as having non-overlapping 99% CIs and an absolute difference between the point estimates of at least 2 percentage points for prevalence estimates ≥ 10% or at least 1 percentage point for prevalence estimates that were both < 10%. Because our primary comparisons of interest were the Asian and PI ethnic groups with the aggregated All Asian group, we also calculated the absolute percentage point difference between each ethnic group and the All Asian group for men and women combined and within sex group. For comparison purposes, we provide the same statistics and analysis of meaningful differences from the All Asian subgroup for whites, blacks, and Hispanic/Latinos. We did not control for multiple comparisons. Because PIs are often combined with Asians in reporting of statistics, in our reporting of results, we refer to PIs in our low to high ranges of prevalence within the Asian group even though data for PIs were not included in the All Asian group estimates.

Results

Diabetes mellitus

Table 3 shows that the prevalence of diabetes for All Asians aged 45–84 was 23.1%, with a range of 15.6% for Chinese to 31.9% for Filipinos and 34.5% for PIs. There was a significant difference in prevalence by sex across all racial/ethnic groups. Diabetes prevalence for women in the All Asian group was 20.4% (range 13.4% of Chinese to 28.7% of Filipinas and 31.1% of PIs) and 26.1% for men (range 17.9% of Chinese to 35.4% of Filipinos and 38.3% of PIs). Prevalence estimates for East Asians (Chinese, Koreans, Japanese, and Southeast Asians) were ≥ 4 percentage points below that of the All Asian group, whereas prevalence estimates for Filipinos, and South Asians were ≥ 6 percentages points above and PI’s > 10 percentage points above the All Asian group.
Table 3
Standardized prevalence estimates of diabetes mellitus, ages 45–84, by race/ethnicity
 
All 45–84 yr
Women 45–84 yr
Men 45–84 yr
All 45–84 yr
  
Age-sex standardized prevalence
 
Age-standardized prevalence
 
Age-standardized prevalence
Absolute percentage point difference from All Asian
 
N
% (99% CI)
N
% (99% CI)
N
% (99% CI)
All
Women
Men
All Asian
274,909
23.1% (22.9–23.3)
148,905
20.4% (20.1–20.7)
126,004
26.1% (25.8–26.5) b
(ref) c
(ref) c
(ref) c
Chinese
87,128
15.6% (15.2–15.9) a
47,034
13.4% (13.0–13.8) a
40,094
17.9% (17.4–18.4) a,b
−7.5
−7.0
−8.2
Korean
8910
18.0% (17.0–19.0) a
5138
14.8% (13.6–16.0) a
3772
21.5% (19.8–23.2) a,b
−5.1
−5.6
−4.6
Japanese
16,886
18.1% (17.4–18.9) a
9891
14.5% (13.7–15.4) a
6995
22.2% (20.9–23.4) a,b
−4.9
−5.9
−3.9
Southeast Asian
30,910
18.7% (18.1–19.4) a
15,104
16.8% (15.9–17.7) a
15,806
21.0% (20.0–21.9) a,b
−4.2
−3.6
− 5.1
Filipino
88,691
31.9% (31.5–32.3) a
50,957
28.7% (28.2–29.2) a
37,734
35.4% (34.8–36.0) a,b
8.8
8.3
9.3
South Asian
35,565
29.1% (28.7–30.0) a
16,430
25.5% (24.5–26.4) a
19,135
33.7% (32.7–34.6) a,b
6.3
5.1
7.6
Native Hawaiian/
Pacific Islander
8453
34.5% (33.1–35.9) a
4051
31.1% (29.1–33.1) a
4402
38.3% (36.3–40.3) a,b
11.4
10.7
12.2
White
non-Hispanic
795,079
12.8% (12.7–12.9) a
421,777
10.6% (10.5–10.7) a
373,302
15.3% (15.1–15.4) a,b
−10.3
−10.2
−10.8
African-American/Black
107,205
24.9% (24.5–25.2)
60,796
23.3% (22.9–23.7) a
46,409
26.6% (26.0–27.1) b
1.8
2.9
0.5
Hispanic/
Latino
210,050
25.3% (25.0–25.5) a
108,366
23.2% (22.8–23.5) a
101,684
27.6% (27.3–28.0) b
2.2
2.8
1.5
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table. This group does not include Native Hawaiian/Pacific Islanders
aNon-overlapping 99% CIs and absolute percentage point difference from All Asian group within sex category of ≥ 2 percentage points
bNon-overlapping 99% CIs and ≥ 2 percentage point difference between women and men
cRef: reference group for race and ethnic group comparisons
While diabetes prevalence for the All Asian group was similar to that of blacks and Latinos, diabetes prevalence for Filipinos, South Asians, and PIs was higher than that of blacks and Latinos, and diabetes prevalence for the East Asian groups was in between the white and black groups.

Hypertension

Table 4 shows that the prevalence of diagnosed hypertension for All Asians aged 45–84 was 42.8%, with a range of 33.8% for Chinese to 56.1% for Filipinos and 53.1% for PIs. Significant sex differences were observed across most ethnic groups. Prevalence among women in the All Asian group was 41.6% (range 32.1% of Chinese to 55.6% of Filipinas) and 44.1% among men (range approximately 35.5% of Chinese and Koreans to 56.7% of Filipinos), with no significant sex difference observed for PIs. Hypertension prevalence for South Asians did not significantly differ from that of the All Asian group, whereas prevalence among Chinese, Koreans, and Southeast Asians was ≥ 7 percentage points below that of the All Asian group, and prevalence among Filipinos and PIs was > 11 percentage points higher than the All Asian group. Hypertension prevalence for Japanese was 3.2 percentage points lower than All Asian for men and women combined, but analysis by sex showed that prevalence was 6 percentage points lower for Japanese women, with no difference between All Asian and Japanese men.
Table 4
Standardized prevalence estimates of diagnosed hypertension, ages 45–84, by race/ethnicity
 
All 45–84 yr
Women 45–84 yr
Men 45–84 yr
All 45–84 yr
 
Age-sex standardized prevalence
 
Age-standardized prevalence
 
Age-standardized prevalence
Absolute percentage point difference from All Asian
 
N
% (99% CI)
N
% (99% CI)
N
% (99% CI)
All
Women
Men
All Asian
274,909
42.8% (42.6–43.0)
148,905
41.6% (41.3–41.9)
126,004
44.1% (43.7–44.4) b
(ref) c
(ref) c
(ref) c
Chinese
87,128
33.8% (33.4–34.1) a
47,034
32.1% (31.6–32.6) a
40,094
35.6% (35.0–36.1) a,b
−9.0
−9.5
−8.5
Korean
8910
33.9% (32.7–35.1) a
5138
32.3% (30.8–33.8) a
3772
35.5% (33.6–37.4) a
− 8.9
− 8.3
−8.6
Japanese
16,886
39.6% (38.7–40.5) a
9891
35.3% (34.1–36.4) a
6995
44.3% (42.9–45.7) a,b
−3.2
−6.3
0.2
Southeast Asian
30,910
35.7% (34.9–36.4) a
15,104
34.2% (33.2–35.2) a
15,806
37.2% (36.2–38.2) a,b
−7.1
−7.4
− 6.9
Filipino
88,691
56.1% (55.7–56.5) a
50,957
55.6% (55.1–56.1) a
37,734
56.7% (56.1–57.3) a
13.3
14.0
12.6
South Asian
35,565
43.4% (42.8–44.1)
16,430
41.5% (40.5–42.4)
19,135
45.5% (44.6–46.4) b
0.6
−0.1
1.4
Native Hawaiian/
Pacific Islander
8453
53.1% (51.7–54.4) a
4051
52.8% (50.8–54.7) a
4402
53.4% (51.5–55.3) a
11.3
11.2
9.3
White
non-Hispanic
795,079
37.5% (37.4–37.7) a
421,777
34.9% (34.9–35.0) a
373,302
40.5% (40.3–40.6) a,b
−5.3
−6.5
−3.6
African-American/Black
107,205
58.0% (57.6–58.3) a
60,796
59.3% (58.9–59.8) a
46,409
56.5% (55.9–57.0) a,b
15.2
17.3
12.4
Hispanic/
Latino
210,050
42.4% (42.2–42.7)
108,366
41.8% (41.4–42.1)
101,684
43.1% (42.8–43.5)
−0.4
0.2
−1.0
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table. This group does not include Native Hawaiian/Pacific Islanders
aNon-overlapping 99% CIs and absolute percentage point difference from All Asian group within sex category of ≥ 2 percentage points
bNon-overlapping 99% CIs and ≥ 2 percentage point difference between women and men
cRef: reference group for race and ethnic group comparisons
Hypertension prevalence for the All Asian group was similar to that of Latinos, i.e., higher than whites and lower than blacks. Among women, hypertension prevalence among the East Asian groups was similar to that of whites, while prevalence for South Asians was similar to Latinas, and prevalence among Filipinos and PIs was closer to that of blacks. Among men, hypertension prevalence among Chinese, Koreans, and Southeast Asians was lower than that of whites, prevalence among Japanese and South Asians was similar to that of Latinos, and prevalence of Filipinos and PIs was similar to that of blacks.

Coronary artery disease (CAD)

CAD prevalence was estimated for ages 45–84 and 65–84. In the text, we focus on prevalence among ages 65–84. Table 5 shows that the prevalence of CAD for All Asians aged 65–84 was 5.4%, with a range of 3.6% for Koreans to 8.3% for South Asians and 9.0% for PIs. A significant sex difference was observed across all ethnic groups. Prevalence among women in the All Asian group was 3.3% (range 1.7% for Koreans to approximately 4% for Filipinas and South Asians, and 5.9% for PIs), and 8.0% among men (range 5.6% of Southeast Asians to 13.0% of South Asians and 12.7% of PIs). CAD prevalence for Japanese and Southeast Asians was similar to that of the All Asian group, whereas prevalence among Chinese and Koreans was significantly lower and that of Filipinos, South Asians, and PIs was significantly higher. This same pattern was also seen in men aged 45–84 (see Additional file 2). CAD prevalence for the All Asian men group was 3.9, 6.4% for South Asian men, 7.4% for PI men, and 2.8% for Chinese and Korean men.
Table 5
Standardized prevalence estimates of diagnosed coronary artery disease, ages 65–84, by race/ethnicity
 
All 65–84 yr
Women 65–84 yr
Men 65–84 yr
All 65–84 yr
  
Age-sex standardized prevalence
 
Age-standardized prevalence
 
Age-standardized prevalence
Absolute percentage point difference from All Asian
 
N
% (99% CI)
N
% (99% CI)
N
% (99% CI)
All
Women
Men
All Asian
81,947
5.4% (5.2–5.6)
44,917
3.3% (3.1–3.6)
37,030
8.0% (7.6–8.3) b
(ref) c
(ref) c
(ref) c
Chinese
29,195
4.2% (3.9–4.5) a
15,346
2.5% (2.1–2.8)
13,849
6.4% (5.8–6.9) a,b
−1.2
−0.8
−1.6
Korean
3055
3.6% (2.7–4.5) a
1796
1.7% (0.9–2.5) a
1259
5.9% (4.2–7.6) a,b
−1.8
−1.6
−2.1
Japanese
7031
4.6% (3.9–5.3)
4250
2.7% (2.1–3.3)
2781
6.9% (5.7–8.1) b
−0.8
−0.6
−1.1
Southeast Asian
6029
4.7% (3.9–5.4)
3046
3.8% (2.9–4.8)
2983
5.6% (4.5–6.8) a,b
−0.7
0.5
−1.4
Filipino
27,566
6.5% (6.1–6.9) a
16,070
4.3% (3.8–4.7)
11,496
9.2% (8.5–10.0) a,b
1.1
1.0
1.2
South Asian
7835
8.3% (7.5–9.1) a
3592
4.4% (3.5–5.3)
4243
13.0% (11.7–14.4) a,b
2.9
1.1
5.0
Native Hawaiian/
Pacific Islander
1757
9.0% (7.2–10.8) a
858
5.9% (3.8–8.0) a
899
12.7% (9.7–15.7) a,b
3.6
2.6
4.7
White
non-Hispanic
318,578
5.9% (5.8–6.0)
173,907
3.7% (3.6–3.8)
144,671
8.5% (8.3–8.7) b
0.5
0.4
0.5
African-American/Black
34,345
6.7% (6.4–7.1) a
20,055
5.7% (5.3–6.1) a
14,290
8.0% (7.4–8.5) b
1.3
2.4
0.0
Hispanic/
Latino
52,439
6.0% (5.7–6.3)
29,027
4.3% (4.0–4.6)
23,412
8.1% (7.6–8.5) b
0.6
1.0
0.1
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table. This group does not include Native Hawaiian/Pacific Islanders
aNon-overlapping 99% CIs and absolute percentage point difference from All Asian group within sex category of ≥1 percentage point
bNon-overlapping 99% CIs and ≥ 1 percentage point difference between women and men
cRef: reference group for race and ethnic group comparisons
CAD prevalence for the All Asian group was similar to that of whites. Among women, CAD prevalence among Chinese, Korean, and Japanese was slightly lower than that of whites, while prevalence for Southeast Asians was similar to whites, and prevalence for Filipinas and South Asians was not significantly different from whites and Latinas. Prevalence among PIs was similar to that of blacks, but because of the narrower age ranges, the CIs overlapped with both blacks and Latinas. Among men, Chinese, Korean, Japanese, and Southeast Asians had a lower CAD prevalence than whites, but CIs overlapped with those of blacks and Latinos. Filipinos had a slightly higher prevalence than whites, but with overlapping CIs, and prevalence among South Asians and PIs was significantly higher than whites, blacks and Latinos.

Obesity

Tables 6 and 7, respectively, show differences in obesity using the standard BMI ≥ 30.0 kg/m2 threshold and lower ≥ 27.5 kg/m2 threshold recommended for Asians. Obesity prevalence in the All Asian group based on the standard threshold was 14.7%, ranging from 7.6 to 8.3% for Southeast Asians, Koreans, and Chinese to approximately 20% for South Asians and Filipinos and 44% for PIs. Obesity prevalence based on the lower Asian threshold was 29.5% for the All Asian group, ranging from approximately 19% for Chinese, Koreans, and Southeast Asians to 35 to 39% for Japanese, Filipinos, and South Asians and 61% for PIs. Based on the standard obesity threshold, with the exception of Southeast Asians, there were meaningful differences between women and men in obesity prevalence in the All Asian and individual Asian and PI ethnic groups. Using the lower Asian threshold, the differences between women and men were larger and significant for all Asian ethnic groups. For all Asian groups except South Asians, obesity prevalence was higher among men than women. PIs did not differ by sex using either obesity threshold. Using the standard obesity threshold, compared to the All Asian group, obesity prevalence was lower for Chinese, Koreans, and Southeast Asians, and higher for Japanese (men only), Filipinos, South Asians, and PIs (Table 6). Using the lower Asian obesity threshold (Table 7) increased the magnitude of the absolute differences between the All Asian and individual Asian ethnic groups.
Table 6
Standardized prevalence estimates of obesity based on BMI ≥ 30.0, ages 45–84, by race/ethnicity
 
All 45–84 yr
Women 45–84 yr
Men 45–84 yr
All 45–84 yr
 
Age-sex standardized prevalence
 
Age-standardized prevalence
 
Age-standardized prevalence
Absolute percentage point difference from All Asian
 
N
% (99% CI)
N
% (99% CI)
N
% (99% CI)
All
Women
Men
All Asian
203,020
14.7% (14.5–14.9)
111,421
13.6% (13.3–13.9)
91,599
15.8% (15.5–16.1)b
(ref) c
(ref) c
(ref) c
Chinese
62,912
8.3% (8.0–8.6) a
34,576
6.8% (6.5–7.2) a
28,336
9.9% (9.4–10.4) a,b
−6.4
−6.4
−5.9
Korean
6510
7.6% (6.8–8.5) a
3817
5.8% (4.8–6.8) a
2693
9.6% (8.1–11.0) a,b
−7.1
−7.4
− 6.2
Japanese
12,292
19.7% (18.8–20.7) a
7257
15.5% (14.3–16.6)
5035
24.3% (22.7–26.0) a,b
5.0
1.9
8.5
Southeast Asian
22,378
7.6% (7.1–8.0) a
11,278
7.3% (6.6–7.9) a
11,100
7.8% (7.2–8.5) a
−7.1
−6.3
−8.0
Filipino
66,959
20.8% (20.4–21.2) a
38,778
19.0% (18.5–19.5) a
28,181
22.6% (22.0–23.3) a,b
6.1
5.4
6.8
South Asian
27,113
20.0% (19.4–20.7) a
12,581
22.4% (21.4–23.3) a
14,532
17.4% (16.6–18.3) a,b
5.3
8.8
1.6
Native Hawaiian/
Pacific Islander
5952
43.6% (41.9–45.4) a
2885
44.5% (42.0–47.0) a
3067
42.7% (40.3–45.0) a
28.9
30.9
26.9
White
non-Hispanic
576,700
36.4% (36.2–36.5) a
304,556
34.7% (34.4–34.9) a
272,144
38.2% (37.9–38.4) a,b
21.7
21.1
22.4
African-American/Black
75,277
50.5% (50.0–50.9) a
42,325
54.9% (54.2–55.5) a
32,952
45.6% (44.9–46.3) a,b
35.8
41.3
29.8
Hispanic/
Latino
154,675
44.6 (44.3–44.9) a
81,307
44.5% (44.1–45.0) a
73,368
44.6% (44.1–45.1) a
29.9
30.9
28.8
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table. This group does not include Native Hawaiian/Pacific Islanders
aNon-overlapping 99% CIs and absolute percentage point difference from All Asian group within sex category of ≥ 1 percentage point for percentages < 10% and ≥ 2 percentage points for percentages ≥ 10%
bNon-overlapping 99% CIs and ≥ 1 percentage point difference between women and men for percentages < 10% and ≥ 2 percentage points for percentages ≥10%
cRef: reference group for race and ethnic group comparisons
Table 7
Standardized prevalence estimates of obesity based on BMI ≥30.0 for whites, blacks, and Hispanic/Latinos and BMI ≥27.5 for Asians and Pacific Islanders, ages 45–84, by race/ethnicity
 
All 45–84 yr
Women 45–84 yr
Men 45–84 yr
All 45–84 yr
  
Age-sex standardized prevalence
 
Age-standardized prevalence
 
Age-standardized prevalence
Absolute percentage point difference from All Asian
 
N
% (99% CI)
N
% (99% CI)
N
% (99% CI)
All
Women
Men
All Asian
203,020
29.5% (29.2–29.8)
111,421
25.7% (25.3–26.0)
91,599
33.6% (33.2–4.0) b
(ref) d
(ref) d
(ref) d
Chinese
62,912
19.2% (18.8–19.6) b
34,576
14.8% (14.3–15.3) a
28,336
23.8% (23.2–24.5) a,b
−10.3
−10.9
−9.8
Korean
6510
19.4% (18.1–20.6) b
3817
13.6% (12.2–15.3) a
2693
25.4% (23.3–27.6) a,b
− 10.1
− 12.1
−8.2
Japanese
12,292
35.6% (34.5–36.8) b
7257
26.8% (25.4–28.2)
5035
45.2% (43.3–47.0) a,b
6.1
1.1
11.6
Southeast Asian
22,378
18.7% (18.0–19.4) b
11,278
16.3% (15.4–17.3) a
11,100
21.1% (20.1–22.2) a,b
−10.8
−9.4
−12.5
Filipino
66,959
39.5% (39.0–40.0) b
38,778
34.5% (33.9–35.2) a
28,181
44.7% (44.0–45.5) a,b
10.0
8.8
11.1
South Asian
27,113
38.2% (37.4–38.9) b
12,581
39.3% (38.2–40.5) a
14,532
36.8% (35.7–37.8) a,b
8.7
13.6
3.2
Native Hawaiian/
Pacific Islander
5952
61.4% (59.7–63.1) b
2885
60.6% (58.2–63.1) a
3067
62.3% (59.9–64.6) a
31.9
34.9
26.7
White
non-Hispanic
576,700
36.4% (36.2–36.5) a
304,556
34.7% (34.4–34.9) a
272,144
38.2% (37.9–38.4) a,b
6.9
9.0
4.6
African-American/Black
75,277
50.5% (50.0–50.9) a
42,325
54.9% (54.2–55.5) a
32,952
45.6% (44.9–46.3) a,b
21.0
29.2
12.0
Hispanic/
Latino
154,675
44.6% (44.3–44.9) a
81,307
44.5% (44.1–45.0) a
73,368
44.6% (44.1–45.1) a
15.1
18.8
11.0
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table. This group does not include Native Hawaiian/Pacific Islanders
aNon-overlapping 99% CIs and absolute percentage point difference from All Asian group within sex category of ≥2 percentage points
bNon-overlapping 99% CIs and ≥ 2 percentage point difference between women and men
cRef: reference group for race and ethnic group comparisons
Using the standard threshold for all racial/ethnic groups, prevalence of obesity was lower for the All Asian and individual Asian ethnic groups than for whites, blacks, and Latinos, with prevalence for PIs relatively close to that of whites. Using the lower threshold for Asians and PIs but retaining the standard threshold for whites, blacks, and Latinos decreased the absolute difference in obesity prevalence between the All Asian group and whites by approximately 10 percentage points for women and men combined and women only and by nearly 20 percentage points for men. Comparing obesity prevalence among the individual Asian ethnic groups to whites, blacks and Latinos using the lower threshold for Asians and PIs and higher for the other 3 groups, obesity prevalence for Japanese, Filipinos, and South Asians became similar to that for whites, Chinese, Korean, and Southeast Asian remained lower than that of whites, and prevalence for PIs was higher than that for blacks. Obesity prevalence of Japanese and Filipino men approximated that of blacks and Latinos, while prevalence among PI women and men was higher than that for blacks and Latinos.

Smoking

Table 8 shows that the prevalence of smoking for All Asians aged 45–84 was 5.9%, with a range of 3.0% for South Asians to 7.7% for Koreans and 10.4% for PIs. However, there was a very large difference in smoking prevalence by sex across all racial/ethnic groups, with women having a much lower prevalence than men. Women in the All Asian group had a prevalence of 2.6% (range 0.9% for South Asians to 4.6% for Japanese and 7.8% for PIs), and prevalence among All Asian men was 9.5% (range 5.2% for South Asians to 13.8% for Southeast Asians and 13.3% for PIs). Compared to the All Asian women group, Chinese, Southeast Asian, and South Asian women were less likely to smoke, while Korean, Filipino, Japanese, and PI women were more likely to smoke. Compared to the All Asian men group, Chinese, Japanese, and South Asian men were less likely to smoke and Koreans, Southeast Asian, Filipino, and PI men were more likely to smoke.
Table 8
Standardized prevalence estimates of smoking, ages 45–84, by race/ethnicity
 
All 45–84 yr
Women 45–84 yr
Men 45–84 yr
All 45–84 yr
 
Age-sex standardized prevalence
 
Age-standardized prevalence
 
Age-standardized prevalence
Absolute percentage point difference from All Asian
 
N
% (99% CI)
N
% (99% CI)
N
% (99% CI)
All
Women
Men
All Asian
262,809
5.9% (5.8–6.0)
144,439
2.6% (2.5–2.7)
118,370
9.5% (9.2–9.7) b
(ref) c
(ref) c
(ref) c
Chinese
82,396
4.8% (4.6–5.0)
45,358
1.4% (1.2–1.5) a
37,038
8.4% (8.0–8.8) a,b
−1.1
−1.2
−1.1
Korean
8370
7.7% (6.9–8.5) a
4911
4.3% (3.5–5.0) a
3459
11.4% (9.9–12.7) a.b
1.8
1.7
1.9
Japanese
16,187
6.3% (5.8–6.8)
9601
4.6% (4.0–5.1) a
6586
8.2% (7.3–9.0) a,b
0.4
2.0
−1.3
Southeast Asian
28,798
7.3% (6.9–7.7) a
14,460
1.3% (1.0–1.5) a
14,338
13.8% (13.0–14.5) a,b
1.4
−1.3
4.3
Filipino
86,274
7.3% (7.1–7.5) a
49,913
4.0% (3.7–4.2) a
36,361
10.9% (10.5–11.3) a,b
1.4
1.4
1.4
South Asian
34,255
3.0% (2.7–3.2) a
15,986
0.9% (0.7–1.2) a
18,269
5.2% (4.7–5.6) a,b
−2.9
−1.7
−4.3
Native Hawaiian/
Pacific Islander
8225
10.4% (9.6–11.3) a
3963
7.8% (6.7–7.8) a
4262
13.3% (11.9–14.6) a,b
4.5
5.2
3.8
White
non-Hispanic
772,492
8.6% (8.6–8.7) a
412,414
7.7% (7.5–7.8) a
360,078
9.7% (9.5–9.8) b
2.7
5.1
0.2
African-American/Black
104,323
11.7% (11.4–11.9) a
59,498
10.3% (9.7–10.6) a
44,825
13.2% (12.8–13.6) a,b
5.8
7.7
3.7
Hispanic/
Latino
203,154
6.4% (6.2–6.5)
106,218
4.5% (4.4–4.7) a
96,936
8.3% (8.1–8.6) a,b
0.5
1.9
−1.2
All Asian group includes aggregated data for the 6 Asian ethnic groups above plus other Asians not represented in the table. This group does not include Native Hawaiian/Pacific Islanders
aNon-overlapping 99% CIs and absolute percentage point difference from All Asian group within sex category of ≥ 1 percentage point
bNon-overlapping 99% CIs and ≥ 1 percentage point difference between women and men
cRef: reference group for race and ethnic group comparisons
Compared to other race groups, smoking prevalence for All Asian women was below that of Latinas, while that for All Asian men was similar to that of whites. Among women, smoking prevalence among Koreans, Japanese, and Filipinas was similar to that of Latinas, while Chinese, Southeast Asians, and South Asians were less likely to smoke; PIs had a smoking prevalence similar to whites. Among men, South Asian smoking prevalence was lower than that of Latinos, was similar to that of whites for Chinese and Japanese men, slightly higher than whites for Filipino and Korean men, and similar to blacks for Southeast Asian and PI men.

Summary of comparisons of Asian ethnic groups with the All Asian category

Figure 1 summarizes comparisons of diabetes, hypertension, CAD, obesity and smoking prevalence estimates for women and men in the six Asian ethnic groups and PIs with those in the All Asian category. Across all conditions and risk factors examined, meaningful differences were observed for Filipino and PI men compared to All Asian men and women in these Asian ethnic groups, except for CAD prevalence among Filipina women which was similar to that of the All Asian women group. South Asian men had a higher prevalence of diabetes, CAD, and obesity, but were not meaningfully different from the All Asian group for hypertension, and they had a lower prevalence of smoking. South Asian women had a higher prevalence of diabetes, CAD, and obesity and lower smoking prevalence compared to All Asian women but were not meaningfully different for hypertension. Chinese and Korean men and women had lower prevalence of obesity and the chronic conditions than their counterparts among All Asians, with the exception that Chinese women were not meaningfully different from All Asian for CAD prevalence. However, in comparison to the All Asian group, Chinese men and women were less likely to be current smokers and Korean men and women were more likely to be smokers.
The comparisons for Japanese and Southeast Asians were mixed. Compared to All Asian, Japanese men and women had lower prevalence of diabetes, similar prevalence of CAD, a higher prevalence of obesity, and higher prevalence of smoking among women and lower among men. Southeast Asians exhibited more differences by sex than the other Asian ethnic groups. Compared to All Asian men, Southeast Asian men had lower prevalence of all the chronic conditions, a lower prevalence of obesity, and higher prevalence of smoking. Compared to All Asian women, Southeast Asian women similarly had a lower prevalence of diabetes, hypertension, and obesity, but were not meaningfully different from All Asian women regarding prevalence of CAD and were also less likely to be smokers.

Discussion

In a 2012 article, Holland and Palaniappan summarized the limitations of most of the current data sources for studying Asian-American ethnic group differences in health and healthcare use [4]. They stressed the importance of collecting data for adequate sample sizes of Asian subgroups to produce stable prevalence estimates and enable comparisons among Asian ethnic groups, as well as including data collection for adults with limited English proficiency and low literacy who often choose not to participate in surveys and research. To our knowledge, ours is the largest cohort study to use EHR data to estimate prevalence of several chronic cardiovascular conditions (diabetes, hypertension, coronary artery disease) and cardiovascular risk factors (obesity and smoking) for an insured population of middle-aged and older Filipino, Chinese, Korean, Japanese, Southeast Asian, South Asian, and Pacific Islander adults in the U.S. and to compare prevalence statistics for these ethnic subgroups, overall and by sex, with those for an aggregated Asian group. Most previous studies of differences between U.S. Asian ethnic groups have estimated and compared prevalence of chronic cardiovascular conditions for populations that include younger adults, even though most of these chronic conditions are not diagnosed until middle or older age. By limiting our study population to adults aged 45–84 and producing separate age-standardized prevalence estimates for men and women, we believe that our study results provide a more precise comparison of statistics for the Asian ethnic groups with the aggregated Asian race group and with whites, blacks, and Latinos, the racial/ethnic groups that are the usual focus of racial/ethnic disparities studies.
Using data age-standardized to the U.S. Census population for ages 45–84, we found large variation across Asian ethnic groups in prevalence for all of the chronic conditions and risk factors we studied. For both men and women aged 45–84, the lowest and highest prevalence of diagnosed diabetes and hypertension differed by ≥ 15 percentage points and for obesity (using the Asian BMI threshold of BMI ≥ 27.5 kg/m2), the difference was > 20 percentage points. Using our criteria for meaningful differences (non-overlapping 99% CIs and absolute difference between prevalence estimates of ≥ 1 percentage point for comparison of prevalence estimates under 10% and ≥ 2 percentage points for prevalence estimates ≥ 10%), the only health condition for which the prevalence estimates for the majority of Asian ethnic groups were not meaningfully different from the aggregated Asian estimate was CAD in the 65–84 age group. However, the prevalence of CAD across all racial/ethnic groups was relatively low.
Overall, Filipinos, South Asians, and PIs tended to have meaningfully higher prevalence estimates than the aggregated Asian group for the chronic conditions, while East Asians (Chinese, Korean, Southeast Asian, and Japanese) had meaningfully lower prevalence estimates for these conditions. This pattern for East Asians did not extend to obesity prevalence, however, as both men and women in the Japanese group had higher prevalence of obesity than the aggregated Asian group, while Chinese, Koreans, and Southeast Asians had a lower prevalence. The pattern for ethnic group differences was also not observed for current smoking, where compared to the aggregated Asian group, prevalence was lower for South Asian men and women, higher for Korean men and women, lower for Japanese men and Southeast Asian women, and higher for Japanese women and Southeast Asian men.
Within racial/ethnic groups, our age-sex standardized prevalence estimates for men and women combined fell approximately midway between prevalence estimates for men and for women. Because of the very large numbers of women and men in our ethnic subgroups, we were able to show that the non-sex-specific age-sex standardized prevalence estimates for an Asian ethnic group in many cases over- or underestimated the age-standardized prevalence estimates for men and women in that ethnic group. In our study population, the age-sex standardized prevalence estimates for men and women combined did not substantively differ from age-standardized estimates for this group. However, this might not be true for populations where there is a greater sex imbalance within ethnic groups. Based on our findings, we recommend that when possible, prevalence of chronic conditions and risk factors should be estimated separately for women and men, and when this is not possible, standardized estimates should adjust for both age and sex.
Because we restricted our analyses to middle-aged and older adults rather than adults ages 18 and over (the population used for most national and state survey-based studies) or ages 35 and over (the population used for most of the PAMF cohort studies), the prevalence estimates from our study are not directly comparable to results of previously published studies. However, our finding that Filipinos and South Asians are at elevated risk for obesity, diabetes, hypertension, and CAD compared to other Asian ethnic groups is in line with results of several previous survey- and EHR-based studies [12, 24, 26, 29, 35, 36]. Additionally, our finding that estimated prevalence of these chronic conditions, obesity, and smoking for women and men in the aggregated Asian group significantly under- or overestimated prevalence for individual Asian ethnic subgroups confirms findings of other EHR- and mortality data-based studies [22, 24, 26, 29].
Our study results suggest that prevalence of chronic health conditions and cardiovascular risk factors in an ethnically diverse Asian population may be affected by the ethnic composition of the Asian group. For example, based on our findings, Asian populations with substantially larger proportions of Filipinos and South Asians than East Asian subgroups would be expected to have higher prevalence of diabetes, cardiovascular conditions, and obesity than Asian populations with larger proportions of East Asians. Forecasting healthcare service needs for a specific Asian population based on estimates for an All Asian group that does not have a similar Asian ethnic group composition to the one used for making the forecasts will potentially produce very inaccurate results. Additionally, comparing chronic disease prevalence, health risks, and healthcare quality metrics across different Asian populations without adjusting for differences in the Asian ethnic group composition of the populations may result in some geographic sub-regions or healthcare populations having a poorer health profile that is due to in part to the ethnic group differences. Also, we compared prevalence estimates for an All Asian/PI group versus All Asian group and found very little difference between the two groups despite the fact that PIs had higher prevalence of cardiovascular conditions and cardiovascular risks than the other Asian ethnic groups. However, this was because PIs were the second smallest group in the study population. The aggregated All Asian and All Asian/PI prevalence estimates grossly underestimated the actual prevalence estimates for the PI group.
Our results also suggest that information about Asian ethnicity in the EHR could lead to meaningful improvements in healthcare delivery, such as system-based prompts that help clinicians identify Asian patients in their adult or child panel who may be candidates for earlier screening and intervention and more frequent monitoring for diabetes and cardiovascular risk conditions. This may become important as care is increasingly delivered to patients through virtual (non-clinic based) encounters, limiting the visual and vital sign information that clinicians have available for monitoring and care planning. Information about Asian ethnicity can also help healthcare teams deliver more culturally competent care, such as using ethnically-tailored dietary assessments and providing culturally-tailored dietary advice and information resources when appropriate. At the population health management level, information about Asian ethnicity in the EHR would facilitate production of Asian-ethnic group specific quality metrics for chronic condition management, cancer screening, and immunizations that could be used to target and evaluate quality improvement efforts. Asian ethnicity information could also be used by health plans to build a medical facility workforce that mirrors the ethnic composition of the patient population being served.
While most health disparities research and policy has focused on the health and health risks of blacks and Hispanic/Latinos compared to whites, our study results suggest that Filipinos, South Asians, and PIs should also be considered higher risk groups compared to East Asians and as well as to whites. While the 2018 revised American Heart Association guidelines now identify South Asians as an ethnic group at heightened risk for atherosclerotic cardiovascular disease [37], no mention is made of heightened risk for Filipinos and PIs. In fact, across all of the cardiovascular conditions and risk factors we studied, prevalence among PIs was consistently higher than other Asian ethnic groups and the same or higher than that for blacks. We thus recommend that PIs never be grouped with Asians for estimating prevalence or as an adjusting factor in epidemiologic research, as this will mask the higher prevalence among PIs, and that information about an Asian/PI group not be extrapolated to forecast needs of a predominantly PI population.
Finally, our study results suggest that health plan member cohorts such as ours with very large Asian ethnic groups that can be linked to EHR data to study differences in health status, health risk factors, and healthcare utilization have great potential to inform clinical practice and public health policy and programs. However, collection of self-reported Asian ethnicity for entry into an EHR system using the ethnicity categories we used for this study or using more granular categories that can be aggregated into these ethnic subgroups would greatly facilitate future research and surveillance of Asian ethnic groups. At the data cleaning stage of the creation of our racial/ethnicity cohort, we found numerous people with a race of American Indian/Alaska Native in their EHR who had a primary language that was a South Asian Indian language or had a South Asian surname. This misclassification potentially could be avoided if there was an option to indicate South Asian (Indian, Pakistani, Afghani, etc.) in an expanded racial/ethnicity checklist when more granular ethnicity is not routinely collected. For U.S. patient populations, dropping “American” from granular ethnicity lists [11] might also improve ability to assign an Asian ethnicity based on EHR data.
Our study had several strengths. First, most previous studies of Asian ethnic group differences have relied on self-report health data obtained from surveys or study questionnaires, while we were able to categorize people based on ICD codes, measured heights and weights, and ascertainment of smoking at time of a clinic visit. Second, the very large numbers of men and women in each of our racial/ethnic subgroups enabled us to produce very stable prevalence estimates with very tight 99% confidence intervals. We were thus able to compare prevalence of the health characteristics for men and women within the same Asian ethnic group and to compare prevalence estimates for different Asian ethnic groups with estimates for All Asian group and other Asian ethnic groups separately by sex. The very large numbers in our racial/ethnic groups also enabled us to focus on middle-aged and older adults. This was important because prevalence of diagnosed diabetes and hypertension is very low before middle age and prevalence of coronary artery disease is very low even in middle age. Third, our study cohort included nearly all adults aged 20–89 who were health plan members during calendar year 2016, making it a truly representative population study. Study cohorts based on population surveys and people recruited for clinical research often under-represent adults who do not communicate well in English or have a very low level of education or literacy. Finally, because all of the adults in the study cohort were insured, receiving care from the same vertically integrated health care system, and living in the same geographic area, this reduced the potential for confounding due to healthcare access and geographic variability in health risk behaviors which is a limitation of studies based on national survey data.
We also acknowledge some potential limitations of the study. Some adults were assigned to an Asian ethnic group based on surname or first and last names, not self-reported or EHR-recorded data. However, we did not rely solely on automated (software-based) assignment of individuals by surname, but also compared first and last names of those assigned based on surname with Asian ethnicity codes for individuals assigned using the EHR and other self-reported data sources before finalizing assignments. Misclassification errors that may have occurred would likely have had limited impact on estimates of ethnic group prevalence statistics. In an EHR-based cohort study, Wang et al. found that across Asian ethnic groups, prevalence of diagnosed Type 2 diabetes among adults with self-identified race/ethnicity was similar to that for the full study cohort which included adults assigned to an Asian ethnicity based on surname [26]. Another potential source of racial/ethnic misclassification is that some individuals had more than one race or ethnicity. When this information came from the EHR, we used the algorithm described in the Methods section to assign individuals to one ethnicity category, but this may have resulted in inaccurate ethnic assignments for some people or confounding due to mixed ethnicity. We do not have information about how long these adults have lived in the U.S., nor what country they were born in if not in the U.S. Another potential limitation is that we did not restrict the cohort to adults who made at least one office visit in 2015 or 2016. This may have resulted in some adults with the chronic conditions we studied being missed, although we have no reason to suspect that under-identification due to non-utilization would be different across racial/ethnic groups. Based on KPNC clinical practice guidelines, middle-aged adults with diabetes, hypertension, and CAD should be routinely coming in to see a doctor or other healthcare provider at least annually and have a diagnosis refresh at time of receiving a medication refill. We further attempted to minimize missed diagnoses due to non-utilization by including diagnoses on the problem list during December 2016. There is always a possibility of inaccuracies in the EHR data, e.g., miscoded diagnoses or errors in data entry of height or weight information. Finally, while we consider the relative homogeneity of the study population with regard to geography and healthcare access as a strength, this may limit the generalizability of our results to uninsured and safety net populations or health plan populations in other geographic regions of the U.S.

Conclusions

In a population of middle-aged and older adult Northern California Kaiser Permanente health plan members, we found meaningful differences between Asian-American ethnic groups in prevalence of chronic cardiovascular conditions and lifestyle risk factors. In most instances, the prevalence estimates for the All Asian group significantly differed from estimates for the individual Asian-American ethnic groups, confirming that reporting statistics for an aggregated Asian-American race group masks meaningful differences between Asian-American ethnic subgroups. We also found significant differences between men and women within racial/ethnic groups which were masked in the overall prevalence estimates for the ethnic groups. Our findings demonstrate the importance of disaggregating data for Asian ethnic groups and for men and women within ethnic groups in order to understand the burden of disease and risks of the heterogeneous Asian-American population and to apply this knowledge to the planning and delivery of healthcare.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12889-019-7683-3.

Acknowledgements

The authors would like to acknowledge Gene Lau MD for his review and input on the manuscript.
This study was approved by Kaiser Permanente Northern California’s Institutional Review Board. The IRB waived the requirement to obtain informed consent as allowed under {§46.116(d)}.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Census Bureau US. Projects of the population by sex, race, and Hispanic origin for the United States: 2010 to 2050. Washington, DC: U.S. Census Bureau; 2009. Census Bureau US. Projects of the population by sex, race, and Hispanic origin for the United States: 2010 to 2050. Washington, DC: U.S. Census Bureau; 2009.
4.
Zurück zum Zitat Holland AT, Palaniappan LP. Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation. Ann Epidemiol. 2012 June;22(6):397–405.CrossRef Holland AT, Palaniappan LP. Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation. Ann Epidemiol. 2012 June;22(6):397–405.CrossRef
5.
Zurück zum Zitat Centers for Medicare & Medicaid Services. Medicare and Medicaid programs; electronic health record incentive program—stage 2; proposed rule. Fed Regist. 2012;77(45):13697–829. Centers for Medicare & Medicaid Services. Medicare and Medicaid programs; electronic health record incentive program—stage 2; proposed rule. Fed Regist. 2012;77(45):13697–829.
7.
Zurück zum Zitat Islam NS, Khan S, Kwon S, Jang D, Ro M, Trinh-Shevrin C. Methodological issues in the collection, analysis, and reporting of granular data in Asian American populations: historical challenges and potential solutions. J Health Care Poor Underserved. 2010;21:1354–81.PubMedPubMedCentral Islam NS, Khan S, Kwon S, Jang D, Ro M, Trinh-Shevrin C. Methodological issues in the collection, analysis, and reporting of granular data in Asian American populations: historical challenges and potential solutions. J Health Care Poor Underserved. 2010;21:1354–81.PubMedPubMedCentral
8.
Zurück zum Zitat Ghosh C. Healthy people 2010 and Asian Americans/Pacific islanders: defining a baseline of information. Am J Public Health. 2003;93:2093–8.CrossRef Ghosh C. Healthy people 2010 and Asian Americans/Pacific islanders: defining a baseline of information. Am J Public Health. 2003;93:2093–8.CrossRef
9.
Zurück zum Zitat Ro MJ, Yee AK. Out of the shadows: Asian Americans, native Hawaiians, and Pacific islanders. Am J Public Health. 2010;100:776–8.CrossRef Ro MJ, Yee AK. Out of the shadows: Asian Americans, native Hawaiians, and Pacific islanders. Am J Public Health. 2010;100:776–8.CrossRef
12.
Zurück zum Zitat Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States. Advance data from vital and health statistics; no 394. Hyattsville, MD: National Center for Health Statistics; 2004–2006. p. 2008. Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States. Advance data from vital and health statistics; no 394. Hyattsville, MD: National Center for Health Statistics; 2004–2006. p. 2008.
13.
Zurück zum Zitat Mui P, Hill SE, Thorpe RJ. Overweight and obesity differences across ethnically diverse subgroups of Asian American men. Am J Mens Health. 2018;12(6):1958–65.CrossRef Mui P, Hill SE, Thorpe RJ. Overweight and obesity differences across ethnically diverse subgroups of Asian American men. Am J Mens Health. 2018;12(6):1958–65.CrossRef
15.
Zurück zum Zitat Huang B, Appel HB, Nicdao EG, Lee HJD, Ai AL. Chronic conditions, behavioral health, and use of health services among Asian American men: the first nationally representative sample. Am J Mens Health. 2013;7(1):66–76.CrossRef Huang B, Appel HB, Nicdao EG, Lee HJD, Ai AL. Chronic conditions, behavioral health, and use of health services among Asian American men: the first nationally representative sample. Am J Mens Health. 2013;7(1):66–76.CrossRef
16.
Zurück zum Zitat Martell BN, Garrett BE, Carabello RS. Disparities in adult cigarette smoking –United States 2002–2005 and 2010–2013. MMWR. 2016:65(30). Martell BN, Garrett BE, Carabello RS. Disparities in adult cigarette smoking –United States 2002–2005 and 2010–2013. MMWR. 2016:65(30).
17.
Zurück zum Zitat Lee JWR, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites. Diabetes Care. 2011;34:353–7.CrossRef Lee JWR, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites. Diabetes Care. 2011;34:353–7.CrossRef
19.
Zurück zum Zitat Mui P, Bowie JV, Juon HS, Thorpe RJ. Ethnic group differences in health outcomes among Asian American men in California. Am J Mens Health. 2017;11(5):1406–14.CrossRef Mui P, Bowie JV, Juon HS, Thorpe RJ. Ethnic group differences in health outcomes among Asian American men in California. Am J Mens Health. 2017;11(5):1406–14.CrossRef
20.
Zurück zum Zitat Bloom B, Black LI. Health of non-Hispanic Asian adults: United States. NCHS data brief, no 247. Hyattsville, MD: National Center for Health Statistics; 2010–2014. p. 2016. Bloom B, Black LI. Health of non-Hispanic Asian adults: United States. NCHS data brief, no 247. Hyattsville, MD: National Center for Health Statistics; 2010–2014. p. 2016.
21.
Zurück zum Zitat Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians fo European, south Asian, and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. Can Med Assoc J. 1999;161:132–8. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians fo European, south Asian, and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. Can Med Assoc J. 1999;161:132–8.
22.
Zurück zum Zitat Jose PO, Frank ATH, Kapphahrik K, Goldstein BA, Eggleston K, Hasings KG, Cullen MR, Palaniappan LP. Cardiovascular disease mortality in Asian Americans. JACC. 2014;64(23):2486–94.CrossRef Jose PO, Frank ATH, Kapphahrik K, Goldstein BA, Eggleston K, Hasings KG, Cullen MR, Palaniappan LP. Cardiovascular disease mortality in Asian Americans. JACC. 2014;64(23):2486–94.CrossRef
23.
Zurück zum Zitat Anand S, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Lancet. 2000;356:279–84.CrossRef Anand S, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Lancet. 2000;356:279–84.CrossRef
24.
Zurück zum Zitat Zhao B, Jose PO, Pu J, Chung S, Acheta IB, Fortmann SP, Palaniappan LP. Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010-2012. Am J Hypertesnion. 2015;28(5):631–9.CrossRef Zhao B, Jose PO, Pu J, Chung S, Acheta IB, Fortmann SP, Palaniappan LP. Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010-2012. Am J Hypertesnion. 2015;28(5):631–9.CrossRef
25.
Zurück zum Zitat Karter AJ, Schillinger D, Adams As, Moffet HH, Liu J, Adler NE, Kanaya AM Elevated rates of diabetes in Pacific Islanders and Asian Subgroups Diabetes Care 2013; 36:574–579. Karter AJ, Schillinger D, Adams As, Moffet HH, Liu J, Adler NE, Kanaya AM Elevated rates of diabetes in Pacific Islanders and Asian Subgroups Diabetes Care 2013; 36:574–579.
26.
Zurück zum Zitat Wang EJ, Wong EC, Dixit AA, Fortmann SP, Linde RB, Palaniappan LP. Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population. Diabetes Res Clin Pract. 2011;93(2):248–54.CrossRef Wang EJ, Wong EC, Dixit AA, Fortmann SP, Linde RB, Palaniappan LP. Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population. Diabetes Res Clin Pract. 2011;93(2):248–54.CrossRef
27.
Zurück zum Zitat Frank ATH, Zhao B, Jose PO, Azar KMJ, Fortmann SP, Palaniappan LP. Racial/ethnic differences in dyslipidemia patterns. Circulation. 2014;129(5):570–9.CrossRef Frank ATH, Zhao B, Jose PO, Azar KMJ, Fortmann SP, Palaniappan LP. Racial/ethnic differences in dyslipidemia patterns. Circulation. 2014;129(5):570–9.CrossRef
28.
Zurück zum Zitat Klatsky A, Klatsky AL TI, Tekawa I. Health problems and hospitalizations among Asian American ethnic groups. Ethn Dis. 2005;15:753–60.PubMed Klatsky A, Klatsky AL TI, Tekawa I. Health problems and hospitalizations among Asian American ethnic groups. Ethn Dis. 2005;15:753–60.PubMed
29.
Zurück zum Zitat Holland AT, Wong EC, Lauderdale DS, Palaniappan LP. Spectrum of cardiovascular diseases in Asian-American racial/ethnic subgroups. Ann Epidemiol. 2011;21(8):608–14.CrossRef Holland AT, Wong EC, Lauderdale DS, Palaniappan LP. Spectrum of cardiovascular diseases in Asian-American racial/ethnic subgroups. Ann Epidemiol. 2011;21(8):608–14.CrossRef
33.
Zurück zum Zitat WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403):157–163. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403):157–163.
34.
Zurück zum Zitat Task 1b: how to generate age-adjusted prevalence rates and means using SAS 9.2 survey procedures [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; [cited 2015 Nov 11]. Available from: www.cdc.gov/nchs/tutorials/NHANES/ NHANESAnalyses/AgeStandardization/Task1b_ SAS92.htm.sk1b_ SAS92.htm. Task 1b: how to generate age-adjusted prevalence rates and means using SAS 9.2 survey procedures [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; [cited 2015 Nov 11]. Available from: www.​cdc.​gov/​nchs/​tutorials/​NHANES/​ NHANESAnalyses/AgeStandardization/Task1b_ SAS92.htm.sk1b_ SAS92.htm.
37.
Zurück zum Zitat Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018 Nov 8. Pii: S0735-1097(18)39034-X. doi: https://doi.org/10.1016/j.jacc.2018.11.003. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018 Nov 8. Pii: S0735-1097(18)39034-X. doi: https://​doi.​org/​10.​1016/​j.​jacc.​2018.​11.​003.
Metadaten
Titel
Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study
verfasst von
Nancy P. Gordon
Teresa Y. Lin
Jyoti Rau
Joan C. Lo
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2019
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7683-3

Weitere Artikel der Ausgabe 1/2019

BMC Public Health 1/2019 Zur Ausgabe